I am a shareholder. My compensation will be when the stock skyrockets. And yes, there are a lot of haters and the company is small so they don't know how to make their information clear to small investors. That's why I write such articles. To me, it seems pretty clear that the FDA is moving forward on CYDY for Covid as laid out by the disclosures and the company meetings. Unfortunately, others have different opinions and still others muddle the waters with misleading disclosures and speculation. This is what short interest does when it has nothing of substance. To me, in most cases, it is just a matter of time before they get approval. Thanks to the shorts those who get it at this price won't have to wait long to make a lot of money. I've been on this board and Seeking Alpha for a long time. You can look me up if you want. I mostly comment.

Hi I posted a Cytodyn article on Friday about the meeting if you want to check it out.

I agree, it is best to have conviction that this company is onto something and keep track of its progress. So far the progress is not bad and hopefully the reward will come shortly, however, one should not be anxious. Still, I feel sorry for those who keep getting hammered short term by misleading information. Anyways, I am hopeful more progress will be displayed in the next month or so.

Thanks I figured people needed clear clarification on what transpired at the last call and where Cytodyn really is at. Their is acknowledgement that effectiveness seems to be most pronounced with moderate to more critical patients. This doesn't mean that it doesn't have an effect on mild patients but that it is best to focus on the most critical patients for now, especially with limited supply. This also works for Cytodyn which needs a win sooner rather than later.

Investors seemed to be thinking approval would happen instantly and there is a lot of misinformation saying they can not uplist as well. Rather than write 100 comments I decided this needed an article. As for the price, I'm not that worried since we may be as little as a month or two out from an approval.

Options and shorts are beneficial to the market in downturns because conversely, they create buyers and generate cash when the market falls supporting the sparks of a recovery. That said, they are still vilified for the initial downturns they often create.

Yay so basically they now need to do nothing and all the good news for the next President is pushed up to help the current president. The Fed gets more political and more permissive to help the present at the cost of the future constantly. What happened to a Fed that tries smoothing out the market cycles and preparing for the worst? What happened to constraint and not playing politics? What happened to the Federal Reserve realizing they don't know the future?

LOL good luck with the vaccine. It will need to be treated like the flu and more effort and expediency should be spent on quick approval and development of therapeutics. Big pharmas want a vaccine because they know they will get a lot of money and nothing may come of it for a year or longer (maybe never). As for the future FAANG stocks (don't include Microsoft please) they are not as broad or as encompassing in tech as the current ones. They should do well but are more prone to technology displacement. I own one or more of these but would not switch unless you wish to replace Facebook with another stock.

I agree medical technology will continue to advance and play a bigger role in the economy. However, it is unclear which will dominate besides maybe ISRG who is the current leader. Even here, there will probably be many different surgical robotics doing different surgeries in the future.

Frankly I'm amazed that it didn't fall back. Beyond pent up demand due to Corona, I don't expect anything more until the US gets its act together and lowers Covid cases permanently at least. That is unless they stop dreaming of a vaccine and get drugs that reduce this to not be life threatening or disables you with reduce lung capacity, heart effects, strokes, and blood clots.

No they have no strong history of dividend payout and no guarantee if they fall on hard times or a bad tech cycle they will keep their dividends flowing. Yes their dividend is good here, but don't rely on it.

It should also provide or incentivize people for taking job training or gaining further education. Our education system is broken as well.